The present invention relates to novel lyophilized and stabilized formulations of PEG-Interferon alpha conjugates and the process for their preparation. The novel formulations of PEG-Interferon alpha conjugates reported by the inventors of this application requires less lyophilisation cycle and are most cost competitive.